BridgeBio Pharma, Inc. Long-Term Debt
BridgeBio Pharma, Inc. (BBIO) had Long-Term Debt of $0 as of 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2025-08-05
- 2025-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2025-03-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2024-12-31: Long-term Debt, Excluding Current Maturities $437.34M.
- 2024-09-30: Long-term Debt, Excluding Current Maturities $436.22M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-29 |
| 2024-12-31 | $437.34M 10-Q · filed 2025-08-05 |
| 2024-09-30 | $436.22M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $435.45M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $434.72M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $446.44M 10-K · filed 2025-02-20 |
| 2023-09-30 | $441.72M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $440.50M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $435.76M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $430.99M 10-K · filed 2024-02-22 |
| 2022-03-31 | $434.11M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $430.75M 10-K · filed 2023-02-23 |
| 2021-09-30 | $103.14M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $102.61M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $90.76M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $92.42M 10-K · filed 2022-02-25 |
| 2020-09-30 | $93.39M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $92.91M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $92.42M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $91.79M 10-K · filed 2021-02-25 |
| 2019-09-30 | $75.02M 10-Q · filed 2019-11-08 |
| 2018-12-31 | $54.51M 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |